BLB&B Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

BLB&B Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,432	Closed	-$219K	–	257
2022 Q1	$219K	Sell	2,432 -255	-9%	-$23.5K	0.01%	239
2021 Q4	$301K	Hold	2,687	–	–	0.02%	221
2021 Q3	$338K	Buy	2,687 +55	+2%	+$7.08K	0.02%	222
2021 Q2	$356K	Buy	+2,632	New	+$346K	0.03%	198

Other funds holding XBI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

BLB&B Advisors's XBI Position: Q2 2022 in Review

BLB&B Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2022, closing a stake of 2,432 shares — an estimated $219K sold.

BLB&B Advisors first reported a position in XBI in Q2 2021 and held it in 4 quarters. The position peaked at $356K in Q2 2021. 704 funds tracked by Wall St. Rank hold XBI as of Q2 2022.

BLB&B Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2022 after selling out during the quarter.
BLB&B Advisors sold 2,432 State Street SPDR S&P Biotech ETF shares in Q2 2022, an estimated $219K.
BLB&B Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q2 2021 and held it in 4 quarters.
BLB&B Advisors's State Street SPDR S&P Biotech ETF position peaked at $356K in Q2 2021.
704 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2022.

Based on BLB&B Advisors's 13F filing for Q2 2022, filed 18 Jul 2022.